PR Newswire (Fri, 8:00AM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
PR Newswire (May 10, 2013)
-
-
-
To learn more about Seeking Alpha Pro, click here.
-
Arena's CEO Discusses Q3 2012 Results - Earnings Call TranscriptTue, Nov 6, 2012 • 10 Comments
-
Arena Pharmaceuticals Inc. Q3 2009 Earnings Call TranscriptTue, Nov 10, 2009
-
Arena Pharmaceuticals, Inc. Q4 2008 Earnings Call TranscriptFri, Mar 13, 2009
-
Arena Pharmaceuticals, Inc. Q3 2008 Earnings Call TranscriptThu, Oct 30, 2008
-
Arena Pharmaceuticals Inc. Q2 2008 Earnings Call TranscriptTue, Aug 5, 2008
-
Arena Pharmaceuticals, Inc. Q1 2008 Earnings Call TranscriptWed, May 7, 2008 • 1 Comment
-
Arena Pharmaceuticals Q4 2007 Earnings Call TranscriptMon, Mar 10, 2008
-
Arena Pharmaceuticals Q3 2007 Earnings Call TranscriptWed, Oct 17, 2007
-
PR Newswire (Fri, 8:00AM)
-
PR Newswire (May 10, 2013)
-
at CNBC.com (May 2, 2013)
-
PR Newswire (May 2, 2013)
-
at CNBC.com (Apr 11, 2013)
-
PR Newswire (Apr 5, 2013)
-
at MarketWatch.com (Mar 4, 2013)
-
PR Newswire (Feb 27, 2013)
-
PR Newswire (Feb 6, 2013)
-
at CNBC.com (Feb 5, 2013)
-
PR Newswire (Jan 2, 2013)
-
at CNBC.com (Dec 17, 2012)
-
at MarketWatch.com (Dec 14, 2012)
-
PR Newswire (Dec 6, 2012)
ARNA vs. ETF Alternatives
Company Description
We are a clinical-stage biopharmaceutical company committed to discovering and developing innovative therapies offering significant medical advances and new options for patients. We are focused on discovering, developing and commercializing oral drugs in four major therapeutic areas:... More
